MANAAL KHAN: Open Payments
NPI 1932861648 · REDFORD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 32 payments from 19 companies in 2025. Trend: 2023 $260 · 2024 $278 · 2025 $640
Food & beverage: $640
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $85 |
| ABBVIE INC. | 3 | $54 |
| Amphastar Pharmaceuticals, Inc. | 2 | $47 |
| Verity Pharmaceuticals Inc. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Corcept Therapeutics | 2 | $40 |
| Amgen Inc. | 2 | $39 |
| Mannkind Corporation | 2 | $38 |
| Neurocrine BioSciences, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $34 |
Products named: UBRELVY, Ozempic, Tlando, JARDIANCE, Korlym, AFREZZA, CRENESSITY, MOUNJARO.
Industry payments across MI — which companies pay providers there.
